These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39226900)

  • 1. Antibodies and complement are key drivers of thrombosis.
    Stark K; Kilani B; Stockhausen S; Busse J; Schubert I; Tran TD; Gaertner F; Leunig A; Pekayvaz K; Nicolai L; Fumagalli V; Stermann J; Stephan F; David C; Müller MB; Heyman B; Lux A; da Palma Guerreiro A; Frenzel LP; Schmidt CQ; Dopler A; Moser M; Chandraratne S; von Brühl ML; Lorenz M; Korff T; Rudelius M; Popp O; Kirchner M; Mertins P; Nimmerjahn F; Iannacone M; Sperandio M; Engelmann B; Verschoor A; Massberg S
    Immunity; 2024 Sep; 57(9):2140-2156.e10. PubMed ID: 39226900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.
    Lood C; Tydén H; Gullstrand B; Sturfelt G; Jönsen A; Truedsson L; Bengtsson AA
    PLoS One; 2014; 9(6):e99386. PubMed ID: 24922069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant glycosylation of anti-SARS-CoV-2 spike IgG is a prothrombotic stimulus for platelets.
    Bye AP; Hoepel W; Mitchell JL; Jégouic S; Loureiro S; Sage T; Vidarsson G; Nouta J; Wuhrer M; de Taeye S; van Gils M; Kriek N; Cooper N; Jones I; den Dunnen J; Gibbins JM
    Blood; 2021 Oct; 138(16):1481-1489. PubMed ID: 34315173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019.
    Petito E; Falcinelli E; Paliani U; Cesari E; Vaudo G; Sebastiano M; Cerotto V; Guglielmini G; Gori F; Malvestiti M; Becattini C; Paciullo F; De Robertis E; Bury L; Lazzarini T; Gresele P;
    J Infect Dis; 2021 Mar; 223(6):933-944. PubMed ID: 33280009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets, complement, and contact activation: partners in inflammation and thrombosis.
    Hamad OA; Bäck J; Nilsson PH; Nilsson B; Ekdahl KN
    Adv Exp Med Biol; 2012; 946():185-205. PubMed ID: 21948369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review.
    Fletcher-Sandersjöö A; Bellander BM
    Thromb Res; 2020 Oct; 194():36-41. PubMed ID: 32569879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.
    Rijkers M; Schmidt D; Lu N; Kramer CSM; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Leebeek FWG; Jansen AJG; Jongerius I; Zeerleder SS; Vidarsson G; Voorberg J; de Haas M
    Haematologica; 2019 Feb; 104(2):403-416. PubMed ID: 30262558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development.
    Subramaniam S; Jurk K; Hobohm L; Jäckel S; Saffarzadeh M; Schwierczek K; Wenzel P; Langer F; Reinhardt C; Ruf W
    Blood; 2017 Apr; 129(16):2291-2302. PubMed ID: 28223279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis.
    Arman M; Krauel K
    J Thromb Haemost; 2015 Jun; 13(6):893-908. PubMed ID: 25900780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the COVID-19 thrombotic catastrophe complement-connected?
    Conway EM; Pryzdial ELG
    J Thromb Haemost; 2020 Nov; 18(11):2812-2822. PubMed ID: 32762081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond.
    Sciaudone A; Corkrey H; Humphries F; Koupenova M
    Circ Res; 2023 May; 132(10):1272-1289. PubMed ID: 37167360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
    Jarlhelt I; Nielsen SK; Jahn CXH; Hansen CB; Pérez-Alós L; Rosbjerg A; Bayarri-Olmos R; Skjoedt MO; Garred P
    Front Immunol; 2021; 12():767981. PubMed ID: 34804055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-Functionalized Adsorbents Eliminate Central Effectors of Immunothrombosis, including Platelet Factor 4, High-Mobility Group Box 1 Protein and Histones.
    Ebeyer-Masotta M; Eichhorn T; Weiss R; Semak V; Lauková L; Fischer MB; Weber V
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions.
    Karpman D; Ståhl AL; Arvidsson I; Johansson K; Loos S; Tati R; Békássy Z; Kristoffersson AC; Mossberg M; Kahn R
    Adv Exp Med Biol; 2015; 865():19-42. PubMed ID: 26306441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement in Hemolysis- and Thrombosis- Related Diseases.
    Luo S; Hu D; Wang M; Zipfel PF; Hu Y
    Front Immunol; 2020; 11():1212. PubMed ID: 32754149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.
    Skendros P; Mitsios A; Chrysanthopoulou A; Mastellos DC; Metallidis S; Rafailidis P; Ntinopoulou M; Sertaridou E; Tsironidou V; Tsigalou C; Tektonidou M; Konstantinidis T; Papagoras C; Mitroulis I; Germanidis G; Lambris JD; Ritis K
    J Clin Invest; 2020 Nov; 130(11):6151-6157. PubMed ID: 32759504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.
    Apostolidis SA; Sarkar A; Giannini HM; Goel RR; Mathew D; Suzuki A; Baxter AE; Greenplate AR; Alanio C; Abdel-Hakeem M; Oldridge DA; Giles JR; Wu JE; Chen Z; Huang YJ; Belman J; Pattekar A; Manne S; Kuthuru O; Dougherty J; Weiderhold B; Weisman AR; Ittner CAG; Gouma S; Dunbar D; Frank I; Huang AC; Vella LA; ; Reilly JP; Hensley SE; Rauova L; Zhao L; Meyer NJ; Poncz M; Abrams CS; Wherry EJ
    Front Immunol; 2022; 13():834988. PubMed ID: 35309299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation.
    Pérez-Campos Mayoral L; Hernández-Huerta MT; Papy-García D; Barritault D; Zenteno E; Sánchez Navarro LM; Pérez-Campos Mayoral E; Matias Cervantes CA; Martínez Cruz M; Mayoral Andrade G; López Cervantes M; Vázquez Martínez G; López Sánchez C; Pina Canseco S; Martínez Cruz R; Pérez-Campos E
    Mol Cell Biochem; 2021 Oct; 476(10):3815-3825. PubMed ID: 34110554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboinflammation Supports Complement Activation in Cancer Patients With COVID-19.
    Peerschke EI; Valentino A; So RJ; Shulman S; Ravinder
    Front Immunol; 2021; 12():716361. PubMed ID: 34491250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.
    Sauter RJ; Sauter M; Reis ES; Emschermann FN; Nording H; Ebenhöch S; Kraft P; Münzer P; Mauler M; Rheinlaender J; Madlung J; Edlich F; Schäffer TE; Meuth SG; Duerschmied D; Geisler T; Borst O; Gawaz M; Kleinschnitz C; Lambris JD; Langer HF
    Circulation; 2018 Oct; 138(16):1720-1735. PubMed ID: 29802205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.